USP Formulary Guide Needs Overhaul To Meet Access Goal, PhRMA, BIO Say
Executive Summary
The U.S. Pharmacopeia should completely overhaul its draft model formulary guidelines for Medicare Part D in order to fulfill its task of creating guidelines that prevent health plans from discriminating against certain Medicare beneficiaries, PhRMA and BIO said
You may also be interested in...
Medicare Rx Coverage Requirements Could Lower Patient Safety, Blues Say
Requiring Medicare drug plans to cover a certain number of drugs could negatively affect patient safety, Excellus BlueCross BlueShield (New York) Chief Pharmacy Officer Joel Owerbach said
Medicare Rx Coverage Requirements Could Lower Patient Safety, Blues Say
Requiring Medicare drug plans to cover a certain number of drugs could negatively affect patient safety, Excellus BlueCross BlueShield (New York) Chief Pharmacy Officer Joel Owerbach said
Rx Discounts Do Not Require Restrictive Formularies, PhRMA Tells USP
Medicare prescription drug plan sponsors will be able to negotiate significant discounts even under a model drug classification system that includes a large number of categories and classes, the Pharmaceutical Research & Manufacturers of America said